From 1 September 2026, the prescriber accreditation requirement for hepatitis B medicines under the PBS Section 100 (s100) Highly Specialised Drugs Program will be removed. As a result, all medical and authorised nurse practitioners will be able to prescribe hepatitis B antiviral treatment without additional specialist accreditation. ASHM is currently updating its website, education and resources to reflect this change.

Find out more

Back

HIV Monitoring Tool for Women

First published:

July 2025

Last published:

July 2025

Overview

This practical two-page resource outlines key considerations for the comprehensive monitoring of cisgender women living with HIV. The resource guides clinicians through history taking, examination, clinical evaluation, and initiation of antiretroviral therapy.

This tool includes the initial and ongoing review schedule details assessment, frequency, and management advice for:

  • psychosocial history;
  • sexual and reproductive health;
  • preventative healthcare and lifestyle;
  • HIV monitoring;
  • co-infections;
  • co-morbidity; and
  • toxicity monitoring.

This tool supports clinicians to deliver evidence-based and holistic care to cisgender women living with HIV. Refer to ASHM’s HIV Monitoring Tool for other patients.